The next release of VarSeq will ship a new product that is highly relevant to our customers working in clinical genomics testing labs. Via VSReports, VarSeq now has the ability to generate clinical-grade reports through its clinical reporting and workflow automation capabilities. These reports are fully customizable, containing focused and actionable data. VS Reports ships with report templates that are modeled off of the guidelines driving ACMG classification, the de-facto gold standard for clinical reporting.
Templates for both hereditary cancer and somatic cancer analysis are included free of charge. They should cover most clinical relevant scenarios, but our Services Organization is happy to work with you to design templates specific to your needs. Additionally, reports can be branded and styled to match the documents that your lab typically produces. With tight integration to your analysis results, robust variant annotation sources relevant to the sample tested can be pulled directly into the report.
By default, reports are created as HTML documents which can be exported to a PDF with a single click. Export formats are completely customizable and can be tailored to integrate with other services that use formats such as XML as their input.
Last but not least, VSReports will ship with a commercial version of OMIM free of charge. In addition, you will have access to a number of other annotation sources including Cosmic, Clinvar and many more that are already standard with any VarSeq license.
VarSeq, VSReports and VSPipeline are key enablers for Precision Medicine, including clinical precision medicine oncology workflows.
About Andreas Scherer
Dr. Andreas Scherer is CEO of Golden Helix. The company has been delivering industry leading bioinformatics solutions for the advancement of life science research and translational medicine for over a decade. Its innovative technologies and analytic services empower scientists and healthcare professionals at all levels to derive meaning from the rapidly increasing volumes of genomic data produced from next-generation sequencing. With its solutions, hundreds of the world’s hospitals and testing labs are able to harness the full potential of genomics to identify the cause of disease, develop genomic diagnostics, and advance the quest for personalized medicine. Golden Helix products and services have been cited in thousands of peer-reviewed publications. Golden Helix is also on the Inc 5000 list of the fastest-growing private companies in the US.
He is also Managing Partner of Salto Partners, Inc, a management consulting firm headquartered in Nevada. He has extensive experience successfully managing growth as well as orchestrating complex turnaround situations. His company, Salto Partners, advises on business strategy, financing, sales, and operations. Clients are operating in the high-tech and life sciences space.
Dr. Scherer holds a Ph.D. in computer science from the University of Hagen, Germany, and a Master of Computer Science from the University of Dortmund, Germany. He is author and co- author of over 20 international publications and has written books on project management, the Internet, and artificial intelligence. His latest book, “Be Fast Or Be Gone”, is a prizewinner in the 2012 Eric Hoffer Book Awards competition, and has been named a finalist in the 2012 Next Generation Indie Book Awards!
View all posts by Andreas Scherer →
That’s wonderful news Andreas.
I look forward to using it in a few months.
Dave
Hi Dave,
VSReports is now available! You can read more about it on our site here: https://www.goldenhelix.com/VarSeq/VarSeq_Reports.html